Article
Real-time monitoring of the reaction of KRAS G12C mutant specific covalent inhibitor by in vitro and in-cell NMR spectroscopy.
Scientific reports - 7 Nov 2023
Zhao Qingci, Haga Ryoka, Tamura Satoko, Shimada Ichio, Nishida Noritaka
Abstract excerpt
KRAS mutations are major drivers of various cancers. Recently, allele-specific inhibitors of the KRAS G12C mutant were developed that covalently modify the thiol of Cys12, thereby trapping KRAS in an inactive GDP-bound state. To study the mechanism of action of the covalent inhibitors in both in vitro and intracellular environments, we used real-time NMR to simultaneously observe GTP hydrolysis and inhibitor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
